Skip to main content
. Author manuscript; available in PMC: 2011 Jul 21.
Published in final edited form as: Clin Cancer Res. 2006 Jan 15;12(2):369–375. doi: 10.1158/1078-0432.CCR-05-1698

Table 1.

Incidence and final tumor volume of SKOV3ip1 cells following s.c. injection

Treatment group Incidence Final tumor volume
(±SE; mm3)
PBS 4 of 5 31.1 ± 7.5
Isoproterenol 5 of 5 129.5 ± 34.9*
Isoproterenol + propranolol 4 of 5 23.3 ± 4.4
*

P < 0.05.